Zhitong Finance App News, Minimally Invasive Brain Science (02172.HK) issued an announcement. The NuWisMen® self™ liquid embolizer developed by the Group passed the National Drug Administration (NMPA) special review application for innovative medical devices and entered the special review process (green channel). This selection is the Group's 8th product to be included in the NMPA's special review of innovative medical devices. It completes the product puzzle in the cerebrovascular malformation treatment section and further enhances the coverage of interventional solutions for all scenarios of cerebrovascular diseases.

Zhitong Finance App News, Minimally Invasive Brain Science (02172.HK) issued an announcement. The NuWisMen® self™ liquid embolizer developed by the Group passed the National Drug Administration (NMPA) special review application for innovative medical devices and entered the special review process (green channel). This selection is the Group's 8th product to be included in the NMPA's special review of innovative medical devices. It completes the product puzzle in the cerebrovascular malformation treatment section and further enhances the coverage of interventional solutions for all scenarios of cerebrovascular diseases.